Tena L. Rosser, MD

Title(s)Associate Professor of Clinical Neurology and Pediatrics
SchoolKeck School of Medicine of Usc
AddressCHL Mail Stop 82
Off Campus
Los Angeles CA 90089
Phone+1 323 361 2471
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Incontinentia pigmenti. Semin Pediatr Neurol. 2024 Oct; 51:101156. Rosser T. PMID: 39389657.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder. Am J Med Genet A. 2024 05; 194(5):e63524. Santoro JD, Jafarpour S, Khoshnood MM, Boyd NK, Vogel BN, Nguyen L, Saucier LE, Partridge R, Tiongson E, Ramos-Platt L, Nagesh D, Ho E, Rosser T, Ahsan N, Mitchell WG, Rafii MS. PMID: 38169137.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials. Clin Trials. 2024 02; 21(1):6-17. Merker VL, Thompson HL, Wolters PL, Buono FD, Hingtgen CM, Rosser T, Barton B, Barnett C, Smith T, Haberkamp D, McManus ML, Baldwin A, Moss IP, Röhl C, Martin S. PMID: 38140900; PMCID: PMC10922038.
      View in: PubMed   Mentions: 1     Fields:    
    4. Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey. Clin Trials. 2024 02; 21(1):73-84. Wolters PL, Ghriwati NA, Baker M, Martin S, Berg D, Erickson G, Franklin B, Merker VL, Oberlander B, Reeve S, Rohl C, Rosser T, Vranceanu AM. PMID: 37962219; PMCID: PMC10922214.
      View in: PubMed   Mentions: 1     Fields:    
    5. A Case of Pediatric Guillain-Barré Syndrome After Respiratory Syncytial Virus Infection. Pediatr Neurol. 2023 09; 146:129-131. Gupta M, Monjazeb S, Rosser T, Santoro JD, Ahsan N. PMID: 37481934.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials. Clin Trials. 2024 02; 21(1):67-72. Cannon A, Sarin KY, Petersen AK, Pichard DC, Wolters PL, Erickson G, Lessing AJ, Li P, Röhl C, Rosser T, Widemann BC, Blakeley JO, Plotkin SR. PMID: 37269078; PMCID: PMC10735167.
      View in: PubMed   Mentions:    Fields:    
    7. Consensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance, Surgical Intervention, and Medical Therapy. J Pediatr Orthop. 2023 Aug 01; 43(7):e531-e537. Xu AL, Suresh KV, Gomez JA, Emans JB, Larson AN, Cahill PJ, Andras LM, White KK, Miller DJ, Murphy JS, Groves ML, Belzberg AJ, Hwang SW, Rosser TL, Staedtke V, Ullrich NJ, Sato AA, Blakeley JO, Schorry EK, Gross AM, Redding GJ, Sponseller PD, Pediatric Spine Study Group. PMID: 37253707; PMCID: PMC10523927.
      View in: PubMed   Mentions: 1     Fields:    
    8. Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey. Am J Med Genet A. 2022 01; 188(1):71-82. Wolters PL, Reda S, Martin S, Al Ghriwati N, Baker M, Berg D, Erickson G, Franklin B, Merker VL, Oberlander B, Reeve S, Rohl C, Rosser T, Toledo-Tamula MA, Vranceanu AM. PMID: 34536052; PMCID: PMC8652613.
      View in: PubMed   Mentions: 4     Fields:    
    9. Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1. Neurology. 2021 08 17; 97(7 Suppl 1):S73-S80. Janusz JA, Klein-Tasman BP, Payne JM, Wolters PL, Thompson HL, Martin S, de Blank P, Ullrich N, Del Castillo A, Hussey M, Hardy KK, Haebich K, Rosser T, Toledo-Tamula MA, Walsh KS, REiNS International Collaboration. PMID: 34230205; PMCID: PMC8594002.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    10. Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials. Neurology. 2021 08 17; 97(7 Suppl 1):S15-S24. Cannon A, Pichard DC, Wolters PL, Adsit S, Erickson G, Lessing AJ, Li P, Narmore W, Röhl C, Rosser T, Widemann BC, Blakeley JO, Plotkin SR, REiNS International Collaboration. PMID: 34230202; PMCID: PMC8594006.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. Nat Med. 2021 01; 27(1):165-173. Fisher MJ, Shih CS, Rhodes SD, Armstrong AE, Wolters PL, Dombi E, Zhang C, Angus SP, Johnson GL, Packer RJ, Allen JC, Ullrich NJ, Goldman S, Gutmann DH, Plotkin SR, Rosser T, Robertson KA, Widemann BC, Smith AE, Bessler WK, He Y, Park SJ, Mund JA, Jiang L, Bijangi-Vishehsaraei K, Robinson CT, Cutter GR, Korf BR, Neurofibromatosis Clinical Trials Consortium, Blakeley JO, Clapp DW. PMID: 33442015; PMCID: PMC8275010.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCTClinical Trials
    12. Dilated cardiomyopathy in a patient with autosomal dominant EEF1A2-related neurodevelopmental disorder. Eur J Med Genet. 2021 Jan; 64(1):104121. Kaneko M, Rosser T, Raca G. PMID: 33307280.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    13. The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities. Oncologist. 2020 07; 25(7):e1109-e1116. Klesse LJ, Jordan JT, Radtke HB, Rosser T, Schorry E, Ullrich N, Viskochil D, Knight P, Plotkin SR, Yohay K. PMID: 32272491; PMCID: PMC7356675.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    14. Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1. J Atten Disord. 2021 06; 25(8):1177-1186. Payne JM, Haebich KM, MacKenzie R, Walsh KS, Hearps SJC, Coghill D, Barton B, Pride NA, Ullrich NJ, Tonsgard JH, Viskochil D, Schorry EK, Klesse L, Fisher MJ, Gutmann DH, Rosser T, Packer RJ, Korf B, Acosta MT, Bellgrove MA, North KN. PMID: 31838937.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    15. Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1. Ann Clin Transl Neurol. 2019 12; 6(12):2555-2565. Payne JM, Hearps SJC, Walsh KS, Paltin I, Barton B, Ullrich NJ, Haebich KM, Coghill D, Gioia GA, Cantor A, Cutter G, Tonsgard JH, Viskochil D, Rey-Casserly C, Schorry EK, Ackerson JD, Klesse L, Fisher MJ, Gutmann DH, Rosser T, Packer RJ, Korf B, Acosta MT, North KN, NF Clinical Trials Consortium. PMID: 31797581; PMCID: PMC6917317.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    16. Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. J Clin Oncol. 2019 12 10; 37(35):3446-3454. Plotkin SR, Duda DG, Muzikansky A, Allen J, Blakeley J, Rosser T, Campian JL, Clapp DW, Fisher MJ, Tonsgard J, Ullrich N, Thomas C, Cutter G, Korf B, Packer R, Karajannis MA. PMID: 31626572; PMCID: PMC7098833.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    17. Reduced higher dimensional temporal dynamism in neurofibromatosis type 1. Neuroimage Clin. 2019; 22:101692. Mennigen E, Schuette P, Vajdi A, Pacheco L, Rosser T, Bearden CE. PMID: 30710873; PMCID: PMC6354288.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. Case Report of Pediatric Channelopathies With UNC80 and KCNJ11 Mutations Having Abnormal Respiratory Control Treated With Positive Airway Pressure Therapy. J Clin Sleep Med. 2018 08 15; 14(8):1419-1425. Hong H, Kamerman-Kretzmer R, Kato R, Rosser T, VanHirtum-Das M, Davidson Ward SL. PMID: 30092901; PMCID: PMC6086955.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity. Neuroimage Clin. 2017; 15:801-811. Ibrahim AFA, Montojo CA, Haut KM, Karlsgodt KH, Hansen L, Congdon E, Rosser T, Bilder RM, Silva AJ, Bearden CE. PMID: 28725547; PMCID: PMC5501884.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    20. Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. Neurology. 2016 Dec 13; 87(24):2575-2584. Payne JM, Barton B, Ullrich NJ, Cantor A, Hearps SJ, Cutter G, Rosser T, Walsh KS, Gioia GA, Wolters PL, Tonsgard J, Schorry E, Viskochil D, Klesse L, Fisher M, Gutmann DH, Silva AJ, Hunter SJ, Rey-Casserly C, Cantor NL, Byars AW, Stavinoha PL, Ackerson JD, Armstrong CL, Isenberg J, O'Neil SH, Packer RJ, Korf B, Acosta MT, North KN, NF Clinical Trials Consortium. PMID: 27956565; PMCID: PMC5207004.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    21. A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I. Ann Clin Transl Neurol. 2016 04; 3(4):266-79. Bearden CE, Hellemann GS, Rosser T, Montojo C, Jonas R, Enrique N, Pacheco L, Hussain SA, Wu JY, Ho JS, McGough JJ, Sugar CA, Silva AJ. PMID: 27081657; PMCID: PMC4818747.
      View in: PubMed   Mentions: 27     Fields:    
    22. Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1. Hum Brain Mapp. 2015 Nov; 36(11):4566-81. Tomson SN, Schreiner MJ, Narayan M, Rosser T, Enrique N, Silva AJ, Allen GI, Bookheimer SY, Bearden CE. PMID: 26304096; PMCID: PMC4619152.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    23. Update from the 2013 International Neurofibromatosis Conference. Am J Med Genet A. 2014 Dec; 164A(12):2969-78. Plotkin SR, Albers AC, Babovic-Vuksanovic D, Blakeley JO, Breakefield XO, Dunn CM, Evans DG, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Kalamarides M, McClatchey AI, Messiaen L, Morrison H, Parkinson DB, Stemmer-Rachamimov AO, Van Raamsdonk CD, Riccardi VM, Rosser T, Schindeler A, Smith MJ, Stevenson DA, Ullrich NJ, van der Vaart T, Weiss B, Widemann BC, Zhu Y, Bakker AC, Lloyd AC. PMID: 25255738; PMCID: PMC4236251.
      View in: PubMed   Mentions: 7     Fields:    
    24. Magnetic resonance spectroscopy markers of axons and astrogliosis in relation to specific features of white matter injury in preterm infants. Neuroradiology. 2014 Sep; 56(9):771-9. Wisnowski JL, Schmithorst VJ, Rosser T, Paquette L, Nelson MD, Haynes RL, Painter MJ, Blüml S, Panigrahy A. PMID: 24903580; PMCID: PMC9242581.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsCTClinical Trials
    25. Spontaneous evolution of an unusual cortical malformation in SOX2 anophthalmia syndrome. Ann Indian Acad Neurol. 2013 Jul; 16(3):422-4. Desai J, Rosser T. PMID: 24101835; PMCID: PMC3788299.
      View in: PubMed   Mentions:
    26. Alterations in white matter microstructure in neurofibromatosis-1. PLoS One. 2012; 7(10):e47854. Karlsgodt KH, Rosser T, Lutkenhoff ES, Cannon TD, Silva A, Bearden CE. PMID: 23094098; PMCID: PMC3477133.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    27. Clinical associations of occipital intermittent rhythmic delta activity. J Child Neurol. 2012 Apr; 27(4):503-6. Desai J, Mitchell WG, Rosser T, Ramos-Platt L, Ahsan N, Langille MM, Toczek MT. PMID: 21940699.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Transient leukoencephalopathy associated with X-linked Charcot-Marie-Tooth disease. J Child Neurol. 2010 Aug; 25(8):1013-6. Rosser T, Muir J, Panigrahy A, Baldwin EE, Boles RG. PMID: 20472869.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    29. Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma. Pediatr Blood Cancer. 2008 Mar; 50(3):699-700. Rook J, Rosser T, Fangusaro J, Finlay J. PMID: 16991134.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. The diverse clinical manifestations of tuberous sclerosis complex: a review. Semin Pediatr Neurol. 2006 Mar; 13(1):27-36. Rosser T, Panigrahy A, McClintock W. PMID: 16818173.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    31. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology. 2005 Feb 08; 64(3):553-5. Rosser TL, Vezina G, Packer RJ. PMID: 15699396.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    32. Postural headache in a child with Marfan syndrome: case report and review of the literature. J Child Neurol. 2005 Feb; 20(2):153-5. Rosser T, Finkel J, Vezina G, Majd M. PMID: 15794185.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    33. Epstein-Barr virus-associated smooth muscle tumor of the basal ganglia in an HIV+ child: case report and review of the literature. Pediatr Dev Pathol. 2004 Mar-Apr; 7(2):198-203. Kumar S, Santi M, Vezina G, Rosser T, Chandra RS, Keating R. PMID: 15022062.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    34. Carotid artery pseudostenosis on MRA. Pediatr Radiol. 2004 Jun; 34(6):507. Rosser T, Vezina G. PMID: 14872295.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Aicardi syndrome. Arch Neurol. 2003 Oct; 60(10):1471-3. Rosser T. PMID: 14568821.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Neurocognitive dysfunction in children with neurofibromatosis type 1. Curr Neurol Neurosci Rep. 2003 Mar; 3(2):129-36. Rosser TL, Packer RJ. PMID: 12583841.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    37. Aicardi syndrome: spectrum of disease and long-term prognosis in 77 females. Pediatr Neurol. 2002 Nov; 27(5):343-6. Rosser TL, Acosta MT, Packer RJ. PMID: 12504201.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    38. Neurofibromas in children with neurofibromatosis 1. J Child Neurol. 2002 Aug; 17(8):585-91; discussion 602-4, 646-51. Rosser T, Packer RJ. PMID: 12403557.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    39. Therapy for plexiform neurofibromas in children with neurofibromatosis 1: an overview. J Child Neurol. 2002 Aug; 17(8):638-41; discussion 646-51. Packer RJ, Rosser T. PMID: 12403563.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    40. Intracranial neoplasms in children with neurofibromatosis 1. J Child Neurol. 2002 Aug; 17(8):630-7; discussion 646-51. Rosser T, Packer RJ. PMID: 12403562.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    Tena's Networks
    Concepts (210)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (23)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.